Determination of specific cardiac biomarkers (CBs) during the diagnosis and management
of adverse cardiovascular events such as acute myocardial infarction (AMI) has become …

Myocardial infarction (MI) is a cardiovascular emergency and the leading cause of death
worldwide. Inflammatory and immune responses are initiated immediately after MI, leading …

Ultrasensitive biosensors have become a necessity in the world of scientific research, and
several signal enhancement strategies have been employed to attain exceptionally low …

Myocardial infarction (MI) is the leading cause of morbidity and mortality worldwide. Despite
extensive efforts to provide early diagnosis and adequate treatment regimens, detection of …

Cardiovascular diseases (CVDs), especially chronic heart failure, threaten many patients'
lives worldwide. Because of its slow course and complex causes, its clinical screening …

The enormous potential of biosensors in medical diagnostics has motivated scientists to
develop newer innovative tools and advance biosensing technologies. The use of cell …

Meat quality can be affected by stress, exhaustion, feed composition, and other physical and
environmental conditions. These stressors can alter the pH in postmortem muscle, leading to …

Thrombin (TB) is a protease enzyme functioning in the blood coagulation cascade. It plays
an important function in a number of diseases, including thromboembolic disease …

The past decade has witnessed extensive research in the field of biosensors, where
nanoaptasensors achieved widespread interest. Aptamer, the single-stranded DNA or RNA …

The enzyme creatine kinase (CK) is one of the most well-established biomarkers in
cardiovascular disease. For acute myocardial infarction (AMI) diagnosis, CK has a clinical …